Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

Registry ID

EUCTR2017-000501-20

Source registry

EUCTR

Phase

PHASE4

Sponsor

Pfizer, Inc.

Last update

2026-08-16

Conditions

• Invasive Fungal Infections

Summary

The primary objective is to collect data on treatment outcomes (clinical and mycological cure), safety and tolerability of treatment with Voriconazole in patients with invasive fungal infections in Slovakia.

Related clinical trials

• Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
• Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
• Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
• L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
• Breath Analysis for the Detection of Invasive Fungal Infections
• Usefulness of PET-CT for Invasive Fungal Infection

View on source registry